The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Cost of healthcare for patients with migraine in five European countries: results from the International Burden of Migraine Study (IBMS)
Open accessAbstract
Migraine is a disabling neurological disease that affects 14.7 % of Europeans. Studies evaluating the economic impact of migraine are complex to conduct adequately and with time become outdated as healthcare systems evolve. This study sought to quantify and compare direct medical costs of chronic migraine (CM) and episodic migraine (EM) in five European countries. Cross-sectional data collected via a web-based survey were screened for migraine and classified as CM (≥15 headache days/month) or EM (<15 headache days/month), and included sociodemographics, resource use data and medication use. Unit cost data, gathered using publicly available sources, were analyzed for each type of service, stratified by migraine status. Univariate and multivariate log-normal regression models were used to examine the relationship between various factors and their impact on total healthcare costs. This economic analysis included data from respondents with migraine in the UK, France, Germany, Italy, and Spain. CM participants had higher level of disability and more prevalent psychiatric disorders compared to EM. CM participants had more provider visits, emergency department/hospital visits, and diagnostic tests; the medical costs were three times higher for CM than EM. Per patient annual costs were highest in the UK and Spain and lower in France and Germany. CM was associated with higher medical resource use and total costs compared to EM in all study countries, suggesting that treatments that reduce headache frequency could decrease the clinical and economic burden of migraine in Europe. Comparing patterns of care and outcomes among countries may facilitate the development of more cost-effective care, and bring greater recognition to patients affected by migraine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Specifically, no detailed assessment of the current treatment pathway, impact on work productivity, or burden associated with premonitory and postdromal phases of migraine is available in individuals experiencing ≥4 MMDs who have had previous prophylactic treatments that failed and continue to experience frequent migraines.”
From My Migraine Voice survey: a global study of disease burden among individuals with migraine for whom preventive treatments have failed (2018) · cites this paper as [6]
In the citing paper
“However, the current understanding of migraine burden among individuals with the highest unmet needs, specifically those experiencing ≥4 monthly migraine days (MMDs) and prior prophylaxis failure, is limited.”
From My Migraine Voice survey: a global study of disease burden among individuals with migraine for whom preventive treatments have failed (2018) · cites this paper as [6]
In the citing paper
“These findings are consistent with the results of the IBMS study, which found that for each of the five European countries studied, chronic migraine (per ICHD-2 criteria, persons with ≥15 MMDs) was associated with additional healthcare costs attributable to an increased use of medical services and associated cost [6].”
From My Migraine Voice survey: a global study of disease burden among individuals with migraine for whom preventive treatments have failed (2018) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevalence and Burden of Migraine in the United States: Data From the American Migraine Study II
Lipton, R. B., Stewart, W. F., Diamond, S., Diamond, M. L., & Reed, M. (2001) · Headache: The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.2001.041007646.x · Cited by 2,268
Self-citationStewart, W. F., Lipton, R. B., Dowson, A. J., & Sawyer, J. (2001) · Neurology · doi:10.1212/wnl.56.suppl_1.s20 · Cited by 1,210
Self-citationNew Appendix Criteria Open for a Broader Concept of Chronic Migraine
Olesen, J., Bousser, M.-G., Diener, H.-C., Dodick, D., First, M., Goadsby, P., Göbel, H., Lainez, M., Lance, J., Lipton, R., et al. (2006) · Cephalalgia · doi:10.1111/j.1468-2982.2006.01172.x · Cited by 909 · cited 1×
“1 defines chronic migraine as C15 headache days per month for at least 3 months, with C8 days per month fulfilling criteria for migraine without aura, in the absence of medication overuse and that cannot be attributed to another causative disorder [6].”
BackgroundSelf-citationBIGAL, M. E., Serrano, D., Buse, D. C., Scher, I., Stewart, W. F., & Lipton, R. B. (2008) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2008.01217.x · Cited by 848
Self-citationThe cost of headache disorders in Europe: the Eurolight project
Linde, M., Gustavsson, A., Stovner, L. J., Steiner, T. J., Barré, J., Katsarava, Z., Lainez, J. M., Lampl, C., Lantéri‐Minet, M., Rastenyte, D., et al. (2012) · European Journal of Neurology · doi:10.1111/j.1468-1331.2011.03612.x · Cited by 741
Self-citationGlobal prevalence of chronic migraine: A systematic review
Natoli, J. L., Manack, A., Dean, B. B., Butler, Q. R., Turkel, C., Stovner, L., & Lipton, R. B. (2009) · Cephalalgia · doi:10.1111/j.1468-2982.2009.01941.x · Cited by 693
Self-citationAn international study to assess reliability of the Migraine Disability Assessment (MIDAS) score
Stewart, W. F., Lipton, R. B., Whyte, J., Dowson, A. J., Kolodner, K. B., Liberman, J. N., & Sawyer, J. P. C. (1999) · Neurology · doi:10.1212/wnl.53.5.988 · Cited by 629
Self-citationBlumenfeld, A., Varon, S., Wilcox, T., Buse, D., Kawata, A., Manack, A., Goadsby, P., & Lipton, R. (2011) · Cephalalgia · doi:10.1177/0333102410381145 · Cited by 627
Self-citationSociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers
Buse, D. C., Manack, A., Serrano, D., Turkel, C., & Lipton, R. B. (2010) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.192492 · Cited by 622
Self-citationClassification of daily and near-daily headaches
Silberstein, S. D., Lipton, R. B., & Sliwinski, M. J. (1996) · Neurology · doi:10.1212/wnl.47.4.871 · Cited by 613
Self-citation
Research works printed but not linked: 2
- Reed ML, Buse DC, Manack AN, Fanning KM, Serrano D, Turkel CC, Lipton RB (2011) Prevalence of chronic migraine (CM), headache-related disability and sociodemographic factors in the US population. Headache 51(S1):28
- Michel P, Auray J, Chicoye A, Dartigues J, Lamure M, Duru G, Henry P, Salamon R (1993) Prise en charge des migraineux en France: coût et recours aux soins. J d’Econ Méd 11:71–80
Cited by
Sorted by citations
Adherence to oral migraine-preventive medications among patients with chronic migraine
Hepp, Z., Dodick, D. W., Varon, S. F., Gillard, P. J., Hansen, R. N., & Devine, E. B. (2014) · Cephalalgia · doi:10.1177/0333102414547138 · Cited by 438
Self-citationAdams, A. M., Serrano, D., Buse, D. C., Reed, M. L., Marske, V., Fanning, K. M., & Lipton, R. B. (2015) · Cephalalgia · doi:10.1177/0333102414552532 · Cited by 305
Self-citationA narrative review on the burden of migraine: when the burden is the impact on people’s life
Leonardi, M., & Raggi, A. (2019) · The Journal of Headache and Pain · doi:10.1186/s10194-019-0993-0 · Cited by 303
European headache federation consensus on the definition of resistant and refractory migraine
Sacco, S., Braschinsky, M., Ducros, A., Lampl, C., Little, P., MaassenVanDenBrink, A., Pozo‐Rosich, P., Reuter, U., de la Torre, E. R., del Río, M. S., et al. (2020) · The Journal of Headache and Pain · doi:10.1186/s10194-020-01130-5 · Cited by 272
Self-citationBonafede, M., Sapra, S. J., Shah, N. A., Tepper, S. J., Cappell, K. A., & Desai, P. (2018) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13275 · Cited by 248
The association between migraine and physical exercise
Amin, F. M., Aristeidou, S., Baraldi, C., Czapińska-Ciepiela, E., Daponte, A., Lenola, D. D., Fenech, C., Kampouris, K., Karagiorgis, G., Braschinsky, M., et al. (2018) · The Journal of Headache and Pain · doi:10.1186/s10194-018-0902-y · Cited by 228
Dodick, D. W., Loder, E., Adams, A. M., Buse, D. C., Fanning, K. M., Reed, M. L., & Lipton, R. B. (2016) · Headache The Journal of Head and Face Pain · doi:10.1111/head.12774 · Cited by 220
Self-citationMartelletti, P., Schwedt, T. J., Lanteri-Minet, M., Quintana, R., Carboni, V., Diener, H.-C., Ruiz de la Torre, E., Craven, A., Rasmussen, A. V., Evans, S., et al. (2018) · The Journal of Headache and Pain · doi:10.1186/s10194-018-0946-z · Cited by 217
Self-citationHallmarks of primary headache: part 1 – migraine
Raggi, A., Leonardi, M., Arruda, M. A., Caponnetto, V., Castaldo, M., Coppola, G., Pietra, A. D., Fan, X., García‐Azorín, D., Gazerani, P., et al. (2024) · The Journal of Headache and Pain · doi:10.1186/s10194-024-01889-x · Cited by 212
Self-citationDirect and Indirect Costs of Chronic and Episodic Migraine in the United States: A Web‐Based Survey
Messali, A. J., Sanderson, J. C., Blumenfeld, A. M., Goadsby, P. J., Buse, D. C., Varon, S. F., Stokes, M. E., & Lipton, R. B. (2016) · Headache The Journal of Head and Face Pain · doi:10.1111/head.12755 · Cited by 203
Self-citationBuse, D. C., Scher, A. I., Dodick, D. W., Reed, M. L., Fanning, K. M., Manack Adams, A., & Lipton, R. B. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.02.013 · Cited by 197
Self-citationBlumenfeld, A. M., Stark, R. J., Freeman, M. C., Orejudos, A. C., & Adams, A. M. (2018) · The Journal of Headache and Pain · doi:10.1186/s10194-018-0840-8 · Cited by 196
Self-citationIbuprofen with or without an antiemetic for acute migraine headaches in adults
Rabbie, R., Derry, S., & Moore, R. A. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008039.pub3 · Cited by 193
A prospective real-world analysis of erenumab in refractory chronic migraine
Lambru, G., Hill, B., Murphy, M., Tylova, I., & Andreou, A. P. (2020) · The Journal of Headache and Pain · doi:10.1186/s10194-020-01127-0 · Cited by 183
Current and emerging evidence-based treatment options in chronic migraine: a narrative review
The Italian chronic migraine group, Agostoni, E. C., Barbanti, P., Calabresi, P., Colombo, B., Cortelli, P., Frediani, F., Geppetti, P., Grazzi, L., Leone, M., et al. (2019) · The Journal of Headache and Pain · doi:10.1186/s10194-019-1038-4 · Cited by 184
Self-citationMigraine Burden of Disease: From the Patient's Experience to a Socio‐Economic View
Agosti, R. M. (2018) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13301 · Cited by 185
Takeshima, T., Wan, Q., Zhang, Y., Komori, M., Stretton, S., Rajan, N., Treuer, T., & Ueda, K. (2019) · The Journal of Headache and Pain · doi:10.1186/s10194-019-1062-4 · Cited by 167
Paracetamol (acetaminophen) with or without an antiemetic for acute migraine headaches in adults
Derry, S., & Moore, R. A. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008040.pub3 · Cited by 162
CGRP and VIP Levels as Predictors of Efficacy of Onabotulinumtoxin Type A in Chronic Migraine
Cernuda‐Morollón, E., Martínez‐Camblor, P., Ramón, C., Larrosa, D., Serrano‐Pertierra, E., & Pascual, J. (2014) · Headache The Journal of Head and Face Pain · doi:10.1111/head.12372 · Cited by 157
Self-citationVo, P. G., Fang, J., Bilitou, A., Laflamme, A. K., & Gupta, S. (2018) · The Journal of Headache and Pain · doi:10.1186/s10194-018-0907-6 · Cited by 157
Economic Burden and Costs of Chronic Migraine
Lantéri‐Minet, M. (2013) · Current Pain and Headache Reports · doi:10.1007/s11916-013-0385-0 · Cited by 137
Chronic Migraine Pathophysiology and Treatment: A Review of Current Perspectives
Mungoven, T. J., Henderson, L. A., & Meylakh, N. (2021) · Frontiers in Pain Research · doi:10.3389/fpain.2021.705276 · Cited by 131
Martelletti, P., Katsarava, Z., Lampl, C., Magis, D., Bendtsen, L., Negro, A., Russell, M. B., Mitsikostas, D. D., & Jensen, R. (2014) · The Journal of Headache and Pain · doi:10.1186/1129-2377-15-47 · Cited by 124
Self-citationDerry, C. J., Derry, S., & Moore, R. A. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009108.pub2 · Cited by 120
Risk of medication overuse headache across classes of treatments for acute migraine
Thorlund, K., Sun‐Edelstein, C., Druyts, E., Kanters, S., Ebrahim, S., Bhambri, R., Ramos, É., Mills, E. J., Lantéri‐Minet, M., & Tepper, S. J. (2016) · The Journal of Headache and Pain · doi:10.1186/s10194-016-0696-8 · Cited by 116
Luedtke, K., Boissonnault, W. G., Caspersen, N., Castien, R., Chaibi, A., Falla, D., Fernández‐de‐las‐Peñas, C., Hall, T. M., Hirsvang, J. R., Horre, T., et al. (2016) · Manual Therapy · doi:10.1016/j.math.2016.02.010 · Cited by 111
Aspirin with or without an antiemetic for acute migraine headaches in adults
Kirthi, V., Derry, S., & Moore, R. A. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008041.pub3 · Cited by 111
Cerritelli, F., Ginevri, L., Messi, G., Caprari, E., Vincenzo, M. D., Renzetti, C., Cozzolino, V., Barlafante, G., Foschi, N., & Provinciali, L. (2015) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2015.01.011 · Cited by 115
on behalf of the REPOSE Principal Investigators, Ahmed, F., Gaul, C., García‐Moncó, J. C., Sommer, K., & Martelletti, P. (2019) · The Journal of Headache and Pain · doi:10.1186/s10194-019-0976-1 · Cited by 108
Self-citationDebate: differences and similarities between tension-type headache and migraine
Onan, D., Younis, S., Wells-Gatnik, W. D., Farham, F., Andruškevičius, S., Abashidze, A., Jusupova, A., Romanenko, Y., Grosu, O., Moldokulova, M. Z., et al. (2023) · The Journal of Headache and Pain · doi:10.1186/s10194-023-01614-0 · Cited by 108
Self-citationCernuda‐Morollón, E., Ramón, C., Larrosa, D., Alvarez, R., Riesco, N., & Pascual, J. (2014) · Cephalalgia · doi:10.1177/0333102414561873 · Cited by 106
Self-citationKinfe, T. M., Pintea, B., Muhammad, S., Zaremba, S., Roeske, S., Simon, B. J., & Vatter, H. (2015) · The Journal of Headache and Pain · doi:10.1186/s10194-015-0582-9 · Cited by 106
Lattanzi, S., Brigo, F., Trinka, E., Vernieri, F., Corradetti, T., Dobran, M., & Silvestrini, M. (2019) · Drugs · doi:10.1007/s40265-019-01069-1 · Cited by 105
Altered kynurenine pathway metabolites in serum of chronic migraine patients
Curto, M., Lionetto, L., Negro, A., Capi, M., Fazio, F., Giamberardino, M. A., Simmaco, M., Nicoletti, F., & Martelletti, P. (2016) · The Journal of Headache and Pain · doi:10.1186/s10194-016-0638-5 · Cited by 104
Self-citationCost of Disorders of the Brain in Spain
Parés‐Badell, O., Barbaglia, G., Jerinic, P., Gustavsson, A., Salvador‐Carulla, L., & Alonso, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105471 · Cited by 98
The exploration of mechanisms of comorbidity between migraine and depression
Zhang, Q., Shao, A., Jiang, Z., Tsai, H., & Liu, W. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14390 · Cited by 101
Negro, A., Koverech, A., & Martelletti, P. (2018) · Journal of Pain Research · doi:10.2147/jpr.s132833 · Cited by 96
Self-citationChen, P. (2016) · Pain Physician · doi:10.36076/ppj/2016.19.e97 · Cited by 95
Negro, A., Sciattella, P., Rossi, D., Guglielmetti, M., Martelletti, P., & Mennini, F. S. (2019) · The Journal of Headache and Pain · doi:10.1186/s10194-019-1068-y · Cited by 89
Self-citationDomínguez, C., Pozo‐Rosich, P., Torres‐Ferrús, M., Hernández-Beltrán, N., Cobo, C. J., Oria, C. G., Lasaosa, S. S., Monzón, M. J., Latorre, G., Alvaro, L. C., et al. (2017) · European Journal of Neurology · doi:10.1111/ene.13523 · Cited by 84
Hanssen, H., Minghetti, A., Magon, S., Rossmeissl, A., Rasenack, M., Papadopoulou, A., Klenk, C., Faude, O., Zahner, L., Sprenger, T., et al. (2017) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/sms.13023 · Cited by 81
Müller, O., Diener, H., Dammann, P. R., Rabe, K., Hagel, V., Sure, U., & Gaul, C. (2013) · Cephalalgia · doi:10.1177/0333102413493193 · Cited by 80
Integrated care for chronic migraine patients: epidemiology, burden, diagnosis and treatment options
Diener, H., Solbach, K., Holle, D., & Gaul, C. (2015) · Clinical Medicine · doi:10.7861/clinmedicine.15-4-344 · Cited by 80
Migraine, Neurogenic Inflammation, Drug Development - Pharmacochemical Aspects
Lukács, M., Tajti, J., Fülöp, F., Toldi, J., Edvinsson, L. I., & Vécsei, L. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666170712163437 · Cited by 79
Dihydroergotamine (DHE) – Then and Now: A Narrative Review
Silberstein, S. D., Shrewsbury, S. B., & Hoekman, J. (2019) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13700 · Cited by 76
Moreno‐Ajona, D., Pérez-Rodríguez, A., & Goadsby, P. J. (2020) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000806 · Cited by 76
Self-citationVo, P. G., Paris, N., Bilitou, A., Valena, T., Fang, J., Naujoks, C., Cameron, A. E., de Vulpillieres, F. D. R., & Cadiou, F. (2018) · Neurology and Therapy · doi:10.1007/s40120-018-0113-0 · Cited by 76
Girolomoni, G., Luger, T. A., Nosbaum, A., Gruben, D. C., Romero, W., Llamado, L. J. Q., & DiBonaventura, M. (2020) · Dermatology and Therapy · doi:10.1007/s13555-020-00459-8 · Cited by 75
Moore, C., Sibbritt, D. W., & Adams, J. (2017) · BMC Neurology · doi:10.1186/s12883-017-0835-0 · Cited by 75
Naproxen with or without an antiemetic for acute migraine headaches in adults
Law, S., Derry, S., & Moore, R. A. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009455.pub2 · Cited by 73
Yerry, J. A., Kuehn, D., & Finkel, A. G. (2015) · Headache The Journal of Head and Face Pain · doi:10.1111/head.12495 · Cited by 75
OnabotulinumtoxinA 155 U in medication overuse headache: a two years prospective study
Negro, A., Curto, M., Lionetto, L., Crialesi, D., & Martelletti, P. (2015) · SpringerPlus · doi:10.1186/s40064-015-1636-9 · Cited by 73
Self-citationSumatriptan plus naproxen for the treatment of acute migraine attacks in adults
Law, S., Derry, S., & Moore, R. A. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008541.pub3 · Cited by 73
Correlation between Migraine Severity and Cholesterol Levels
Tana, C., Santilli, F., Martelletti, P., Vincenzo, A. D., Cipollone, F., Davı̀, G., & Giamberardino, M. A. (2014) · Pain Practice · doi:10.1111/papr.12229 · Cited by 72
Self-citationLate-life migraine accompaniments: A narrative review
Vongvaivanich, K., Lertakyamanee, P., Silberstein, S. D., & Dodick, D. W. (2014) · Cephalalgia · doi:10.1177/0333102414560635 · Cited by 70
Irimia, P., Garrido‐Cumbrera, M., Lasaosa, S. S., Aguirre-Vazquez, M., Correa-Fernández, J., Colomina, I., & Pozo‐Rosich, P. (2021) · Scientific Reports · doi:10.1038/s41598-021-87352-2 · Cited by 69
Banzi, R., Cusi, C., Randazzo, C., Sterzi, R., Tedesco, D., & Moja, L. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002919.pub3 · Cited by 69
Touche, R. L. (2014) · Pain Physician · doi:10.36076/ppj.2014/17/95 · Cited by 67
A Systematic Review of the Economic and Humanistic Burden of Gout
Shields, G., & Beard, S. M. (2015) · PharmacoEconomics · doi:10.1007/s40273-015-0288-5 · Cited by 65
Long-term outcomes of occipital nerve stimulation for chronic migraine: a cohort of 53 patients
Miller, S., Watkins, L. D., & Matharu, M. S. (2016) · The Journal of Headache and Pain · doi:10.1186/s10194-016-0659-0 · Cited by 61
Diclofenac with or without an antiemetic for acute migraine headaches in adults
Derry, S., Rabbie, R., & Moore, R. A. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008783.pub3 · Cited by 61
CGRP Monoclonal Antibodies for Migraine: Rationale and Progress
Yuan, H., Lauritsen, C. G., Kaiser, E. A., & Silberstein, S. D. (2017) · BioDrugs · doi:10.1007/s40259-017-0250-5 · Cited by 63
Mechtler, L. L., Saikali, N. P., McVige, J. W., Hughes, O. B., Traut, A., & Adams, A. M. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2021.788159 · Cited by 58
Is Migraine Primarily a Metaboloendocrine Disorder?
Rainero, I., Govone, F., Gai, A., Vacca, A., & Rubino, E. (2018) · Current Pain and Headache Reports · doi:10.1007/s11916-018-0691-7 · Cited by 57
Burden and costs of migraine in a Swedish defined patient population – a questionnaire-based study
Hjalte, F., Olofsson, S., Persson, U., & Linde, M. (2019) · The Journal of Headache and Pain · doi:10.1186/s10194-019-1015-y · Cited by 55
Mehuys, E., Crombez, G., Paemeleire, K., Adriaens, E., Hees, T. J. V., Demarche, S. F., Christiaens, T., Bortel, L. M. V., Tongelen, I. V., Remon, J., et al. (2018) · Journal of Pain · doi:10.1016/j.jpain.2018.09.003 · Cited by 55
Luedtke, K., Basener, A., Bedei, S., Castien, R., Chaibi, A., Falla, D., Fernández-de-las-Peñas, C., Gustafsson, M., Hall, T., Jull, G., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-029855 · Cited by 52
Zolmitriptan for acute migraine attacks in adults
Bird, S., Derry, S., & Moore, R. A. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008616.pub2 · Cited by 52
Buse, D. C., Yugrakh, M. S., Lee, L. K., Bell, J., Cohen, J. M., & Lipton, R. B. (2020) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2020.20100 · Cited by 50
Self-citationKawata, A. K., Shah, N. A., Poon, J. L., Shaffer, S., Sapra, S. J., Wilcox, T. K., Shah, S., Tepper, S. J., Dodick, D. W., & Lipton, R. B. (2021) · Headache The Journal of Head and Face Pain · doi:10.1111/head.14053 · Cited by 51
Self-citationPiccinni, C. P., Cevoli, S., Ronconi, G., Dondi, L., Calabria, S., Pedrini, A., Esposito, I., Favoni, V., Pierangeli, G., Cortelli, P., et al. (2019) · The Journal of Headache and Pain · doi:10.1186/s10194-019-1027-7 · Cited by 49
Self-citationDoane, M. J., Gupta, S., Vo, P. G., Laflamme, A. K., & Fang, J. (2019) · Pain and Therapy · doi:10.1007/s40122-019-0133-1 · Cited by 46
Headache-related health resource utilisation in chronic and episodic migraine across six countries
Sanderson, J. C., Devine, E. B., Lipton, R. B., Bloudek, L. M., Varon, S. F., Blumenfeld, A. M., Goadsby, P. J., Buse, D. C., & Sullivan, S. D. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-305197 · Cited by 45
Self-citationNegro, A., Seidel, J. L., Houben, T., Yu, E. S., Rosen, I., Arreguin, A. J., Yalcin, N., Shorser-Gentile, L., Pearlman, L., Sadhegian, H., et al. (2020) · The Journal of Headache and Pain · doi:10.1186/s10194-020-01155-w · Cited by 45
Self-citationIrimia, P., García‐Azorín, D., Núñez, M., Díaz‐Cerezo, S., Polavieja, P., Panni, T., Sicras-Navarro, A., Sicras‐Mainar, A., & Ciudad, A. (2022) · The Journal of Headache and Pain · doi:10.1186/s10194-022-01448-2 · Cited by 44
Lipton, R. B., Buse, D. C., Adams, A. M., Varon, S. F., Fanning, K. M., & Reed, M. L. (2017) · Headache: The Journal of Head and Face Pain · doi:10.1111/head.13028 · Cited by 43
Self-citationBerra, E., Sances, G., Icco, R. D., Avenali, M., Berlangieri, M., Paoli, I. D., Bolla, M., Allena, M., Ghiotto, N., Guaschino, E., et al. (2015) · The Journal of Headache and Pain · doi:10.1186/s10194-015-0532-6 · Cited by 43
Korolainen, M. A., Kurki, S. H., Lassenius, M. I., Toppila, I., Costa‐Scharplatz, M., Purmonen, T. T., & Nissilä, M. (2019) · The Journal of Headache and Pain · doi:10.1186/s10194-019-0964-5 · Cited by 42
Early Use of Erenumab vs Nonspecific Oral Migraine Preventives
Pozo‐Rosich, P., Doležil, D., Paemeleire, K., Stępień, A., Stude, P., Snellman, J., Arkuszewski, M., Stites, T. E., Ritter, S., López, C. L., et al. (2024) · JAMA Neurology · doi:10.1001/jamaneurol.2024.0368 · Cited by 41
Campos, F., Sobrino, T., Pérez‐Mato, M., Osorio, X. R., Leira, R., Blanco, M., Mirelman, D., & Castillo, J. (2013) · Cephalalgia · doi:10.1177/0333102413487444 · Cited by 41
Raggi, A., Leonardi, M., Sansone, E., Curone, M., Grazzi, L., & D’Amico, D. (2019) · European Journal of Neurology · doi:10.1111/ene.14034 · Cited by 41
Barad, M. J., Sturgeon, J. A., Hong, J. S., Aggarwal, A. K., & Mackey, S. (2021) · Headache The Journal of Head and Face Pain · doi:10.1111/head.14129 · Cited by 42
Migraine and stroke: correlation, coexistence, dependence - a modern perspective
Borończyk, M., Zduńska, A., Węgrzynek‐Gallina, J., Grodzka, O., Lasek‐Bal, A., & Domitrz, I. (2025) · The Journal of Headache and Pain · doi:10.1186/s10194-025-01973-w · Cited by 40
Hökenek, N. M., Erdogan, M. O., Hökenek, Ü. D., Algın, A., Tekyol, D., & Seyhan, A. U. (2020) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2020.01.024 · Cited by 40
Estimating the savings associated with a migraine‐free life: results from the Spanish Atlas
Irimia, P., Garrido‐Cumbrera, M., Lasaosa, S. S., Braçe, O., Colomina, I., Mur, C. B., & Pozo‐Rosich, P. (2020) · European Journal of Neurology · doi:10.1111/ene.14431 · Cited by 39
Economic burden of chronic migraine in OECD countries: a systematic review
Eltrafi, A., Shrestha, S., Ahmed, A., Mistry, H., Paudyal, V., & Khanal, S. (2023) · Health Economics Review · doi:10.1186/s13561-023-00459-2 · Cited by 36
Hedblom, A. H., Axelsson, I., Jacobson, L. K., Tedroff, J., & Borgström, F. (2020) · The Journal of Headache and Pain · doi:10.1186/s10194-020-01162-x · Cited by 36
Orlando, V., Mucherino, S., Monetti, V. M., Trama, U., & Menditto, E. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-038972 · Cited by 36
Economic burden of migraine in Latvia and Lithuania: direct and indirect costs
Lublóy, Á. (2019) · BMC Public Health · doi:10.1186/s12889-019-7461-2 · Cited by 35
Marcus, S. C., Shewale, A. R., Silberstein, S. D., Lipton, R. B., Young, W. B., Viswanathan, H. N., & Doshi, J. A. (2020) · Cephalalgia · doi:10.1177/0333102420915167 · Cited by 35
Self-citationGasparini, R., Landa, P., Amicizia, D., Icardi, G., Ricciardi, W., de Waure, C., Tànfani, E., Bonanni, P., Lucioni, C., Testi, A., et al. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2016.1160177 · Cited by 34
Stark, C., Stark, R. J., Limberg, N., Rodrigues, J. P., Cordato, D. J., Schwartz, R., & Jukic, R. (2019) · The Journal of Headache and Pain · doi:10.1186/s10194-019-1030-z · Cited by 33
Lipton, R. B., Tepper, S. J., Silberstein, S. D., Kudrow, D., Ashina, M., Reuter, U., Dodick, D. W., Zhang, F., Rippon, G. A., Cheng, S., et al. (2020) · Cephalalgia · doi:10.1177/0333102420973994 · Cited by 32
Self-citationThe therapeutic armamentarium in migraine is quite elderly
Martelletti, P. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2015.982089 · Cited by 32
Self-citationAdolescent Perspectives on the Burden of a Parent's Migraine: Results from the CaMEO Study
Buse, D. C., Powers, S. W., Gelfand, A. A., VanderPluym, J. H., Fanning, K. M., Reed, M. L., Adams, A. M., & Lipton, R. B. (2018) · Headache: The Journal of Head and Face Pain · doi:10.1111/head.13254 · Cited by 30
Self-citationDavies, B., Gaul, C., Martelletti, P., García‐Moncó, J. C., & Brown, S. M. (2017) · The Journal of Headache and Pain · doi:10.1186/s10194-017-0802-6 · Cited by 30
Self-citationTreatment of Chronic Migraine with OnabotulinumtoxinA: Mode of Action, Efficacy and Safety
Szok, D., Csáti, A., Vécsei, L., & Tajti, J. (2015) · Toxins · doi:10.3390/toxins7072659 · Cited by 30
Eller, M., & Goadsby, P. J. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/ern.13.24 · Cited by 30
Self-citationScreening for the metabolic syndrome in subjects with migraine
Streel, S., Donneau, A., Dardenne, N., Hoge, A., Albert, A., Schoenen, J. E., & Guillaume, M. (2016) · Cephalalgia · doi:10.1177/0333102416672494 · Cited by 29
Tetzlaff-Lelleck, V., Schulz, F., Witt, O., Kühn, G., Klein, D., Gendolla, A., Evers, S., Gaul, C., Thaçi, D., Sina, C., et al. (2022) · Nutrients · doi:10.3390/nu14142927 · Cited by 28
Metadata
- Authors
- Bloudek, L. M., Stokes, M., Buse, D. C., Wilcox, T. K., Lipton, R. B., Goadsby, P. J., Varon, S. F., Blumenfeld, A. M., Katsarava, Z., Pascual, J., Lanteri-Minet, M., Cortelli, P., & Martelletti, P.
- Affiliations
- Allergan (United States) (US)
- Albert Einstein College of Medicine (US)
- University of California, San Francisco (US)
- Essen University Hospital (DE)
- Hospital Universitario Central de Asturias (ES)
- University of Bologna (IT)
- Azienda Ospedaliera Sant'Andrea (IT)
- Corresponding author
- Bloudek, L. M.
- ORCID
- Venue
- The Journal of Headache and Pain
- Published
- 2012-05-29
- Volume
- 13
- Issue
- 5
- Pages
- 361-378
- ISSN
- 1129-2369 (ISSN-L)
- 1129-2377
- PMC
- PMC3381065
- OpenAlex
- W2094473459
- Cited by
- 339
- References
- 38
- Citations by year
- 2026: 6 · 2025: 16 · 2024: 26 · 2023: 19 · 2022: 18 · 2021: 38 · 2020: 36 · 2019: 34 · 2018: 25 · 2017: 25 · 2016: 17 · 2015: 17 · 2014: 30 · 2013: 25 · 2012: 6
- FWCI
- 17.76
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- The Journal of Headache and Pain (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research Portal (King's College London) (publishedVersion, other-oa)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, cc-by)
- eScholarship (California Digital Library) (submittedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Funders
- University of Washington
- Allergan
- Topics
- Health Sciences › Medicine › Clinical Neurology › Migraine and Headache Studies
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Musculoskeletal pain and rehabilitation
- Keywords
- migraine, chronic migraine, episodic migraine, health care costs, direct medical costs, health care utilization, disability, psychiatric comorbidity, emergency department visits, hospital visits, diagnostic testing, medication use, cross-national comparison
- MeSH terms
- Cross-Sectional Studies, Europe, Female, Persons with Disabilities, Health Surveys, Humans, Male, Migraine Disorders, Health Care Costs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
